DSM Food Specialties retains the dairy portion of Lafti business through a licence agreement, reflecting the company’s strategy to concentrate on food and beverage probiotic applications. Lafti probiotics
The license also includes a portfolio of small-molecule selective histone deacetylase (HDAC) enzyme inhibitors including the first-ever selective inhibitor of HDAC6. Acetylon is currently focused on the development
Reportedly, the collaboration spans a range of research projects. Thomas Jensen, founder and CEO of Intomics, said: “We are extremely pleased to be working with LEO Pharma on
The goal of the research collaboration is to demonstrate whether genomic sequencing of cancer tissue can provide clues for treatment strategies for these individuals. The research study brings
Mr Boussard replaces Jacques Lhomel, who is taking retirement to pursue a number of personal projects. Biocitech said that Mr Boussard, joins Biocitech after a long and successful
The 708-DS supports a broad set of applications ranging from manual dissolution testing to automated, high-throughput analysis. Varian said that its 708-DS provides flexibility to match the needs
Stentys said that the self-expanding feature of the platform is designed to ensure optimal apposition of a stent in the critical initial hours and days after an acute
UK-based BP is a manufacturer of self adhesive labels for the pharmaceutical, healthcare, cosmetic and food & drink markets, often providing them as part of an authentication solution.
However, both companies will continue to collaborate in the field of prostate cancer. Loic Maurel, president of management board at ExonHit, said: “ExonHit’s technology was able to produce
With capacity for 35 patients and healthy volunteers, the extension brings the total number of Phase I beds in London to 105 and globally to 385. This is
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.